- Filed
- Feb 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2023 | 120.7M sh |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $654.61M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $273.79M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $293.61M |
| Current Assets | FY 2024 · Dec 31, 2023 | $815.68M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.08B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 107.94M sh |
| Capex restated | FY 2024 · Dec 31, 2022 | $1.35M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $5.43M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.36 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.36 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $82.95M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $50.26M |
| Net Income | FY 2024 · Dec 31, 2022 | −$39.35M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$30.22M |
| Revenue | FY 2024 · Dec 31, 2022 | $289.38M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $482.2M |